** Shares of radiology center operator RadNet RDNT.O fall 2% to $52 in extended trading
** RDNT says it is acquiring iCAD ICAD.O, an AI breast cancer detection software maker, in an all-stock acquisition valued about $103 million
** RDNT is offering $3.61/shr of ICAD common stock, representing a significant 87% premium to ICAD's closing price on Tuesday
** Shares of iCAD up 73% at $3.31 in extended trading
** Deal expected to close in the second or third quarter of 2025
** RDNT says the deal is expected to add over 1,500 healthcare-provider locations across 50 countries to its network
** As of last close, RDNT down 24% and ICAD up 5.5%, YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.